The Pfizer-BioNTech COVID-19 vaccine is 91% effective in 5- to 11-year-olds, new study results showBusiness Insider • 10/22/21
Pfizer Says Its Covid Vaccine Is 91% Effective At Preventing Infection For Young KidsForbes • 10/22/21
A Year Since Pfizer's Big Breakthrough, Are Vaccine Stocks Still Worth Investing In?Forbes • 10/21/21
Pfizer says its booster shot has 95.6% efficacy against COVID-19 amid the Delta variantBusiness Insider • 10/21/21
Pfizer and BioNTech say Phase 3 trial found booster dose of COVID vaccine had 95.6% efficacy against diseaseMarket Watch • 10/21/21
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 VaccineBusiness Wire • 10/21/21
Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer's PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in AdultsBusiness Wire • 10/20/21
Pfizer's vaccine cuts the risk of COVID-19 hospitalization in teens by 93%, CDC analysis saysBusiness Insider • 10/20/21
Less Talk, More Action: New Report Sponsored by ViiV Healthcare Provides Roadmap to Achieve Health Equity by 2040Business Wire • 10/20/21
Pfizer's Covid Vaccine 93% Effective At Preventing Teen Hospitalizations, CDC Study FindsForbes • 10/19/21
CDC study shows Pfizer Covid vaccine is 93% effective against hospitalization in 12- to 18-year-oldsCNBC • 10/19/21
Pfizer CEO says he's gotten a COVID vaccine booster shot and most of us will, tooMarket Watch • 10/18/21
Pfizer and AstraZeneca vaccines were effective as prior infection, U.K. study findsMarket Watch • 10/18/21